...
首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation.
【24h】

Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation.

机译:表现为基底膜薄症伴重度蛋白尿或肾病综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

Thin basement membrane disease (TBMD) is a condition originally defined as diffuse thinning of the glomerular basement membrane (GBM) associated with hematuria in all patients. Although proteinuria has been described in up to 60% of patients with TBMD, it is almost always mild, with a 24-hour excretion mostly of less than 500 mg. We describe eight patients (four men and four women between 32 and 66 years of age) with TBMD who presented with heavy proteinuria or nephrotic syndrome. Among the seven cases with family history, hematuria was noted in five. All patients had a long history of microscopic hematuria, with episodic gross hematuria in two. Renal biopsies showed diffuse thinning of the GBM in each patient (mean between 185.3 x 29.8 nm and 232.6 x 34.5 nm versus control between 325 x 35 nm and 350 x 15 nm). Three cases showed thinning of GBM only (group I); the remaining five cases showed thinning of GBM associated with focal segmental glomerulosclerosis. All three patients of group I presented with nephrotic syndrome and normal renal function. Treatment with steroids resulted in remission of nephrotic syndrome in two, whereas nephrotic syndrome persisted in the untreated patient. Among the five patients in group II, nephrotic syndrome and normal renal function at presentation were noted in two, whereas the other three had heavy proteinuria (2.2, 2. 5, and 2.6 g/d, respectively) associated with mildly decreased renal function (serum creatinine 1.8, 1.3, and 1.5 mg/dL, respectively). At last follow-up, although the renal function was stable in all five, only the three who received steroid treatment had remission or marked improvement of proteinuria. Hematuria, however, persisted in all eight patients of both groups. Whether specific gene mutations are translated into structural changes responsible for both excessive GBM thinning and increased transcapillary permeability remains to be elucidated. Alternatively, the heavy proteinuriaephrotic syndrome may not be related to TBMD, but rather is the manifestation of associated glomerular diseases. Follow-up, including a response to steroids, supports the latter hypothesis.
机译:薄基底膜疾病(TBMD)是一种最初定义为与所有患者血尿相关的肾小球基底膜(GBM)弥漫性变薄的疾病。尽管已经有多达60%的TBMD患者描述了蛋白尿,但它几乎总是轻度的,24小时排泄量大多少于500 mg。我们描述了8名TBMD患者(4名男性和4名女性,年龄在32至66岁之间),他们患有严重的蛋白尿或肾病综合症。在7例有家族史的病例中,有5例出现血尿。所有患者都有镜下血尿的悠久历史,发作性肉眼血尿有两次。肾脏活检显示每位患者的GBM弥漫性变薄(平均值在185.3 x 29.8 nm和232.6 x 34.5 nm之间,而对照在325 x 35 nm和350 x 15 nm之间)。 3例仅表现为GBM变薄(第一组);其余5例表现为与局灶性节段性肾小球硬化相关的GBM变薄。第一组的所有三例患者均出现肾病综合征和肾功能正常。类固醇治疗可导致2例肾病综合征的缓解,而未经治疗的患者仍存在肾病综合征。在第二组的五名患者中,有两名发现了肾病综合征和出现时肾功能正常,而其他三名患有严重的蛋白尿(分别为2.2、2、5和2.6 g / d),伴有肾功能轻度下降(血清肌酐分别为1.8、1.3和1.5 mg / dL)。在最后一次随访中,尽管所有五位患者的肾功能均稳定,但只有三位接受类固醇治疗的患者可缓解或明显改善蛋白尿。然而,两组的所有八名患者均存在血尿。是否需要将特定的基因突变转化为导致GBM过度变薄和跨毛细血管通透性增加的结构变化尚待阐明。或者,重蛋白尿/肾病综合征可能与TBMD无关,而与相关的肾小球疾病有关。随访,包括对类固醇的反应,支持后一种假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号